: Microdroplet platforms provide an amplification-free
CRISPR diagnostic method by confining reactions to enhance local
target concentration, but spontaneous Cas12a cleavage during
droplet generation can generate false-positive signals that com
promise quantitative accuracy. To address this, LUCID (Light-Up
Cas12a In microDroplets), a photoactivatable CRISPR/Cas12a
microdroplet platform was developed for amplification-free, digital
nucleic acid detection. The strategy employs a photocloaking
modification on crRNA that temporarily blocks Cas12a activity.
Brief UV irradiation after droplet formation synchronously acti
vates trans-cleavage across all droplets, eliminating premature
signal gener... More
: Microdroplet platforms provide an amplification-free
CRISPR diagnostic method by confining reactions to enhance local
target concentration, but spontaneous Cas12a cleavage during
droplet generation can generate false-positive signals that com
promise quantitative accuracy. To address this, LUCID (Light-Up
Cas12a In microDroplets), a photoactivatable CRISPR/Cas12a
microdroplet platform was developed for amplification-free, digital
nucleic acid detection. The strategy employs a photocloaking
modification on crRNA that temporarily blocks Cas12a activity.
Brief UV irradiation after droplet formation synchronously acti
vates trans-cleavage across all droplets, eliminating premature
signal generation. The platform detected HPV16 DNA down to
100 copies/μL and exhibited excellent specificity against non-target
sequences. LUCID accurately discriminated genotyped HPV16/18 in multiple cervical cancer cell lines. By uniquely integrating optical
controllability, amplification-free operation, and digital readout, LUCID effectively eliminates false positives and enables absolute
quantification, offering a versatile and robust platform for diverse nucleic acid detection applications.